Factors which influence phosphorus removal in hemodialysis;Factores en la eliminación de fósforo en hemodiálisis

Nefrologia

Volumn 27, Issue 1, 2007, Pages 46-52

  Gallar Ruiz, Paloma ^a   Ortiz, M ^a   Ortega, O ^a   Rodriguez I ^a   Seijas, V ^a   Carreno A ^a   Oliet, A ^a   Vigil, A ^a  

^a HOSPITAL SEVERO OCHOA   (Spain)

Author keywords

Hemodialysis; Phosphate removal

Indexed keywords

PHOSPHATE;

ADULT; AGED; ARTICLE; ARTIFICIAL MEMBRANE; BLOOD; FEMALE; HEMODIAFILTRATION; HUMAN; MALE; METABOLISM; METHODOLOGY; MIDDLE AGED; RENAL REPLACEMENT THERAPY; TIME;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HEMODIAFILTRATION; HUMANS; MALE; MEMBRANES, ARTIFICIAL; MIDDLE AGED; PHOSPHATES; RENAL DIALYSIS; TIME FACTORS;

EID: 34447101247     PISSN: 02116995     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Gutzwiller JP, Schneditz D, Huber AR, Schindler C, Gutzwiller F, Zehn der CE. Estimating phosphate removal in hemodialysis: An additional tool to quantify dialysis dose. Nephrol Dial Transplant 17: 1037-1044, 2002.
2. Slatopolsky E, Robson AM, El Kan I, Bricker NS. Control of phosphate excretion in uremic man. J Clin Invest 46: 1865-1870, 1968.
3. Delmez JA, Slatopolsky E. Hyperphosphatemia: Its consequences and treatment in chronic renal failure. Am J Kidney Dis 19: 303-307, 1992.
4. Milliner DS, Zinmeister AR, Lieberman E, Landing B. Soft Tissue calcification in pediatric patients with end-stage renal disease. Kidney Int 38: 931-935, 1990.
5. Shigematsu T, Kono T, Satoh K, Yokoyama K, Yoshida T, Hosoya T, Shirai K. Phosphate overload accelerates vascular calcium deposition in end-stage renal disease patients. Nephrol Dial Transplant 18: III 86-III 89, 2003.
6. Block GA, Hulbert-Shearon TE, Levin NW, Port FK. Association of serum phosphorus and calciumxphosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis 31: 607-609, 1998.
7. Goodman WG, Golding J, Kuizon BD, Yoon C,Gales B, Siden B, Wang Y, Chung J, Emerck A, Greasser LL, Elashoff RM, Salusky IB. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 342: 1478-1483, 2000.
8. Marchais ST, Metivier F, Guerin AP, London GM. Association of hyperphosphatemia with haemodynamic disturbances in end-stage renal disease. Nephrol Dial Transplant 14: 2178-2183, 1999.
9. Amann K, Gross ML, London GM, Ritz E. Hyperphosphatemia: a silent killer of patients with renal failure? Nephrol Dial Transplant 14: 2085-2087, 1999.
10. Mucsi I, Herez G. Control of serum phosphate in patients with renal failure. New aproaches. Nephrol Dial Transplant 13: 2457-2460, 1998.
11. Messa P, Gropuzza M, Cleva M, Boscutti G, Mioni G, Cruciati A, Mazzolini S, Malison MR. Behaviour of phosphate removal with different dialysis schedules. Nephrol Dial Transplant 13 (Supl. 6): 43-48, 1998.
12. Buoncristiani U, Quintaliani G, Gozzari M, Giombini L, Ragailo M. Daily dialysis: Long-term clinical metabolic results. Kidney Int (Supl. 24): s137-s140, 1998.
13. Ratanarat R, Brendolan A, Volker G, Bonello M, Salvatory G, Andrikos E, Yavuz A, Crepaldi C, Ronco C. Blood Purif 23: 83-90, 2005.
14. a, 2002.
15. Gartaldon F, Brendolan A, Crepaldi C, Frisone P, Zamboni S, dÍntini V, Poulin S, Hector R, Granziero A, Martins K, Gellert R, Inguaggiato P, Ronco C. Effect of novel manufacturing technology on blood and dialysate flow distribution in a new low flux «Alfa polysulfone» hemodialyzer. Int J Artif Organs 26: 105-112, 2003.
16. Innes A, Charra B, Burden RP, Morgan AG, Laurent G. The eefect of long, slow hemodialysis on patient survival. Nephrol Dial Transplant 14: 919-922, 1999.
17. Musci I, Herez G, Urdall R, Ouwendyk M, Pierratos A. Control of serum phosphate without any Phosphate binders in patients treated with slow nocturnal home hemodialysis. Kidney Int 53: 1399-1404, 1998.
18. Spalding EM, Chamney PW, Fanington K. Phosphate kinetics during hemodialysis. Evidence for biphasic regulation. Kidney Int 61: 655-667, 2002.
19. Gutzwiller JP, Schneditz D, Huber AR, Schindler C, Garbani E, Zehnder CE. Increasing blood flow increases KT/Vurea and potassium removal but fails to improve phosphate removal. Clin Nephrol 59: 130-136, 2003.
20. Jindal KK, McDougall J, Woods B,Nowakowski L, Goldstein MB. A study of the basic principles determining the performance of several high-flux dializers. Am J Kidney Dis 14: 507-511, 1989.
21. Albalate M, Fernández C, López MD, Gago C, Jarraiz A, Pulido A, González A, Santana H, Hernando P. ¿Es posible aumentar la eliminación de fósforo en hemodiálisis convencional? Nefrología 23 (6): 520-527, 2003.
22. Minutolo R, Bellizzi R, Cioffi M; Iodice C, Giannattasio P, Andreucci M, Terracciano V, Di Ioro BR, Conte G, DE Nicola L. Postdialytic rebound of serum phosphorous: pathogenic and clinical insights.
23. Mandolfo S, Malberti F, Imbarciati E, Cogliati P, Gauly A. Impact of blood and dialysate flow and surface on performance of new polysulfone hemodializers. Int J Artif Organs 26: 113-120, 2003.
24. Katopodis KP, Chala A, Kaliouski E, Takouli L, Kalaitzidis R, Theodorou J, Siampoulos KC. Role of dialyzer membrane on the overal phosphate kinetics during hemodialysis. Blood Purif 23 (5): 359-64, 2005.
25. Polkinghorne KR, McDonald SP, Atkins RC, Kerr PG. Vascular access and all-cause mortality: a propensity score analysis. J Am Soc Nephrol 15: 477-486, 2004.